AMENDMENT NO. 11 TO FINANCING AGREEMENTFinancing Agreement • May 31st, 2022 • TherapeuticsMD, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 31st, 2022 Company Industry JurisdictionAMENDMENT NO. 11 TO FINANCING AGREEMENT, dated as of May 27, 2022 (this “Amendment”), to the Financing Agreement, dated as of April 24, 2019 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Financing Agreement”), by and among THERAPEUTICSMD, INC., a Nevada corporation (“Company” or “Borrower”), certain Subsidiaries of Borrower, as Guarantors, the Lenders from time to time party thereto, and SIXTH STREET SPECIALTY LENDING, INC., a Delaware corporation (“Sixth Street”), as administrative agent for the Lenders (in such capacity, together with its successors and assigns in such capacity, the “Administrative Agent”).
CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(B)(10). SUCH EXCLUDED INFORMATION IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.Agreement and Plan of Merger • May 31st, 2022 • TherapeuticsMD, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledMay 31st, 2022 Company Industry JurisdictionThis Agreement and Plan of Merger (“Agreement”) is made and entered into as of May 27, 2022 (the “Agreement Date”) by and among Athene Parent, Inc., a Nevada corporation (“Parent”), Athene Merger Sub, Inc., a Nevada corporation and wholly owned direct subsidiary of Parent (“Merger Sub”), and TherapeuticsMD, Inc., a Nevada corporation (the “Company”). Each of Parent, Merger Sub and the Company are referred to herein as a “Party” and collectively as the “Parties”. Certain capitalized terms used in this Agreement are defined in Exhibit A.
AMENDMENT NO. 10 TO FINANCING AGREEMENTFinancing Agreement • May 31st, 2022 • TherapeuticsMD, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 31st, 2022 Company Industry JurisdictionAMENDMENT NO. 10 TO FINANCING AGREEMENT, dated as of May 27, 2022 (this “Amendment”), to the Financing Agreement, dated as of April 24, 2019 (as amended, restated, supplemented or otherwise modified from time to time, the “Financing Agreement”), by and among THERAPEUTICSMD, INC., a Nevada corporation (“Company” or “Borrower”), certain Subsidiaries of Borrower, as Guarantors, the Lenders from time to time party thereto, and SIXTH STREET SPECIALTY LENDING, INC., a Delaware corporation (“Sixth Street”), as administrative agent for the Lenders (in such capacity, together with its successors and assigns in such capacity, the “Administrative Agent”).